Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2021-09-08 History
Report ID 139880
Drug Identification Number 02472171
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name Atropine Sulfate Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 5mL
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-02
Estimated end date
Actual end date 2021-09-07
Shortage status Resolved
Updated date 2021-09-08
Company comments Item has been discontinued.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-09-08 English Compare
v7 2021-09-07 French Compare
v6 2021-09-07 English Compare
v5 2021-08-03 English Compare
v4 2021-08-02 French Compare
v3 2021-08-02 English Compare
v2 2021-05-25 French Compare
v1 2021-05-25 English Compare